Bookmark and Share
Mitomycin (CID 5746) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(932)
 
 
Inactive(543)
 
 
Inconclusive(62)
 
 
Unspecified(902)
 
 
Top Targets:
7TM GPCR Srx(36)
 
 
 
7TM GPCR Srsx(32)
 
 
 
p450(16)
 
 
 
 
NR LBD ER(9)
 
 
 
 
 
NR LBD AR(8)
 
 
 
 
 
BioAssay Types:
Confirmatory(1043)
 
 
 
 
 
Literature(618)
 
 
 
 
 
Screening(336)
 
 
 
 
Summary(24)
 
 
 
 
BioActivity Types:
IC50(897)
 
 
 
 
 
Potency(189)
 
 
 
 
 
EC50(16)
 
 
Ki(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 2387    Data Row: 2439   Total Pages: 122   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103176321]
IC50 2.21e-05SANGER: Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay. [AID741784, Type: confirmatory]
View
2
[SID103176321]
IC50 3.25e-05SANGER: Inhibition of human MOLT-4 cell growth in a cell viability assay. [AID742374, Type: confirmatory]
View
3
[SID103176321]
IC50 0.000119SANGER: Inhibition of human J82 cell growth in a cell viability assay. [AID742254, Type: confirmatory]
View
4
[SID103176321]
IC50 0.000128SANGER: Inhibition of human 697 cell growth in a cell viability assay. [AID741935, Type: confirmatory]
View
5
[SID103176321]
IC50 0.000149SANGER: Inhibition of human KYSE-510 cell growth in a cell viability assay. [AID742296, Type: confirmatory]
View
6
[SID103176321]
IC50 0.000151SANGER: Inhibition of human NCI-H2170 cell growth in a cell viability assay. [AID741731, Type: confirmatory]
View
7
[SID103176321]
IC50 0.000167SANGER: Inhibition of human BE-13 cell growth in a cell viability assay. [AID741975, Type: confirmatory]
View
8
[SID103176321]
IC50 0.000249SANGER: Inhibition of human LC-2-ad cell growth in a cell viability assay. [AID742313, Type: confirmatory]
View
9
[SID103176321]
IC50 0.000308SANGER: Inhibition of human IMR-5 cell growth in a cell viability assay. [AID742247, Type: confirmatory]
View
10
[SID103176321]
IC50 0.00031SANGER: Inhibition of human EW-16 cell growth in a cell viability assay. [AID742160, Type: confirmatory]
View
11
[SID103176321]
IC50 0.000638SANGER: Inhibition of human MC-IXC cell growth in a cell viability assay. [AID742338, Type: confirmatory]
View
12
[SID103176321]
IC50 0.000676SANGER: Inhibition of human SW872 cell growth in a cell viability assay. [AID741914, Type: confirmatory]
View
13
[SID103176321]
IC50 0.000796SANGER: Inhibition of human NCI-H2228 cell growth in a cell viability assay. [AID741735, Type: confirmatory]
View
14
[SID103176321]
ED50 0.001Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under hypoxic condition. [AID67635, Type: Literature]
View
15
[SID103176321]
IC50 0.001In vitro inhibitory activity against K562 leukemia cells [AID94811, Type: Literature]
View
16
[SID103176321]
IC50 0.00107SANGER: Inhibition of human NALM-6 cell growth in a cell viability assay. [AID742386, Type: confirmatory]
View
17
[SID103176321]
IC50 0.00108Inhibitory activity of compound for AA8 cells to reduce cell density by 50% (exposed to compound for 4 hours) [AID45745, Type: Literature]
View
18
[SID103176321]
IC50 0.00156SANGER: Inhibition of human ES4 cell growth in a cell viability assay. [AID742148, Type: confirmatory]
View
19
[SID103176321]
IC50 0.00164SANGER: Inhibition of human KE-37 cell growth in a cell viability assay. [AID742268, Type: confirmatory]
View
20
[SID103176321]
IC50 0.00168SANGER: Inhibition of human IST-MEL1 cell growth in a cell viability assay. [AID742249, Type: confirmatory]
View